Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
http://link.springer.com/content/pdf/10.1007/s10620-007-8102-1.pdf
Reference18 articles.
1. Murch SH, Lamkin VA, Savage MO, Walker–Smith JA, MacDonald TT: Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 32(8):913–917, 1991
2. Breese EJ, Michie CA, Nicholls SW, et al.: Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106(6):1455–1466, 1994
3. Hyams JS: Use of infliximab in the treatment of Crohn’s disease in children and adolescents. J Pediatr Gastroenterol Nutr 33 (Suppl 1):S36–S39, 2001
4. Kugathasan S, Levy MB, Saeian K, et al.: Infliximab retreatment in adults and children with Crohn’s disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol 97(6):1408–1414, 2002
5. Kugathasan S: Prolonged duration of response to infliximab in early pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr 33 (Suppl 1):S40–S43, 2001
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic strategies for stricturing Crohn’s disease in childhood: a systematic review;Pediatric Surgery International;2021-01-25
2. Growth and Puberty in Children with Inflammatory Bowel Diseases;Biomedicines;2020-10-29
3. Infliximab-induced Depression and Suicidal Behavior in Adolescent with Crohn’s Disease: Case Report and Review of Literature;Pediatric Quality & Safety;2019-11
4. The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection;Journal of Pediatric Gastroenterology & Nutrition;2019-03
5. Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood;Alimentary Pharmacology & Therapeutics;2019-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3